Cargando…

Distinct inhibitory effects on mTOR signaling by ethanol and INK128 in diffuse large B-cell lymphoma

BACKGROUND: The mechanistic target of rapamycin, (mTOR) kinase plays a pivotal role in controlling critical cellular growth and survival pathways, and its aberrant induction is implicated in cancer pathogenesis. Therefore, suppression of active mTOR signaling has been of great interest to researcher...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazan-Mamczarz, Krystyna, Peroutka, Raymond J, Steinhardt, James J, Gidoni, Moriah, Zhang, Yongqing, Lehrmann, Elin, Landon, Ari L, Dai, Bojie, Houng, Simone, Muniandy, Parameswary A, Efroni, Sol, Becker, Kevin G, Gartenhaus, Ronald B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350884/
https://www.ncbi.nlm.nih.gov/pubmed/25849580
http://dx.doi.org/10.1186/s12964-015-0091-0
_version_ 1782360251006189568
author Mazan-Mamczarz, Krystyna
Peroutka, Raymond J
Steinhardt, James J
Gidoni, Moriah
Zhang, Yongqing
Lehrmann, Elin
Landon, Ari L
Dai, Bojie
Houng, Simone
Muniandy, Parameswary A
Efroni, Sol
Becker, Kevin G
Gartenhaus, Ronald B
author_facet Mazan-Mamczarz, Krystyna
Peroutka, Raymond J
Steinhardt, James J
Gidoni, Moriah
Zhang, Yongqing
Lehrmann, Elin
Landon, Ari L
Dai, Bojie
Houng, Simone
Muniandy, Parameswary A
Efroni, Sol
Becker, Kevin G
Gartenhaus, Ronald B
author_sort Mazan-Mamczarz, Krystyna
collection PubMed
description BACKGROUND: The mechanistic target of rapamycin, (mTOR) kinase plays a pivotal role in controlling critical cellular growth and survival pathways, and its aberrant induction is implicated in cancer pathogenesis. Therefore, suppression of active mTOR signaling has been of great interest to researchers; several mTOR inhibitors have been discovered to date. Ethanol (EtOH), similar to pharmacologic mTOR inhibitors, has been shown to suppress the mTOR signaling pathway, though in a non-catalytic manner. Despite population studies showing that the consumption of EtOH has a protective effect against hematological malignancies, the mechanisms behind EtOH’s modulation of mTOR activity in cells and its downstream consequences are largely unknown. Here we evaluated the effects of EtOH on the mTOR pathway, in comparison to the active-site mTOR inhibitor INK128, and compared translatome analysis of their downstream effects in diffuse large B-cell lymphoma (DLBCL). RESULTS: Treatment of DLBCL cells with EtOH suppressed mTORC1 complex formation while increasing AKT phosphorylation and mTORC2 complex assembly. INK128 completely abrogated AKT phosphorylation without affecting the structure of mTORC1/2 complexes. Accordingly, EtOH less profoundly suppressed cap-dependent translation and global protein synthesis, compared to a remarkable inhibitory effect of INK128 treatment. Importantly, EtOH treatment induced the formation of stress granules, while INK128 suppressed their formation. Microarray analysis of polysomal RNA revealed that although both agents primarily affected cell growth and survival, EtOH and INK128 regulated the synthesis of mostly distinct genes involved in these processes. Though both EtOH and INK128 inhibited cell cycle, proliferation and autophagy, EtOH, in contrast to INK128, did not induce cell apoptosis. CONCLUSION: Given that EtOH, similar to pharmacologic mTOR inhibitors, inhibits mTOR signaling, we systematically explored the effect of EtOH and INK128 on mTOR signal transduction, components of the mTORC1/2 interaction and their downstream effectors in DLBCL malignancy. We found that EtOH partially inhibits mTOR signaling and protein translation, compared to INK128’s complete mTOR inhibition. Translatome analysis of mTOR downstream target genes established that differential inhibition of mTOR by EtOH and INK128 distinctly modulates translation of specific subsets of mRNAs involved in cell growth and survival, leading to differential cellular response and survival. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12964-015-0091-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4350884
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43508842015-03-06 Distinct inhibitory effects on mTOR signaling by ethanol and INK128 in diffuse large B-cell lymphoma Mazan-Mamczarz, Krystyna Peroutka, Raymond J Steinhardt, James J Gidoni, Moriah Zhang, Yongqing Lehrmann, Elin Landon, Ari L Dai, Bojie Houng, Simone Muniandy, Parameswary A Efroni, Sol Becker, Kevin G Gartenhaus, Ronald B Cell Commun Signal Research BACKGROUND: The mechanistic target of rapamycin, (mTOR) kinase plays a pivotal role in controlling critical cellular growth and survival pathways, and its aberrant induction is implicated in cancer pathogenesis. Therefore, suppression of active mTOR signaling has been of great interest to researchers; several mTOR inhibitors have been discovered to date. Ethanol (EtOH), similar to pharmacologic mTOR inhibitors, has been shown to suppress the mTOR signaling pathway, though in a non-catalytic manner. Despite population studies showing that the consumption of EtOH has a protective effect against hematological malignancies, the mechanisms behind EtOH’s modulation of mTOR activity in cells and its downstream consequences are largely unknown. Here we evaluated the effects of EtOH on the mTOR pathway, in comparison to the active-site mTOR inhibitor INK128, and compared translatome analysis of their downstream effects in diffuse large B-cell lymphoma (DLBCL). RESULTS: Treatment of DLBCL cells with EtOH suppressed mTORC1 complex formation while increasing AKT phosphorylation and mTORC2 complex assembly. INK128 completely abrogated AKT phosphorylation without affecting the structure of mTORC1/2 complexes. Accordingly, EtOH less profoundly suppressed cap-dependent translation and global protein synthesis, compared to a remarkable inhibitory effect of INK128 treatment. Importantly, EtOH treatment induced the formation of stress granules, while INK128 suppressed their formation. Microarray analysis of polysomal RNA revealed that although both agents primarily affected cell growth and survival, EtOH and INK128 regulated the synthesis of mostly distinct genes involved in these processes. Though both EtOH and INK128 inhibited cell cycle, proliferation and autophagy, EtOH, in contrast to INK128, did not induce cell apoptosis. CONCLUSION: Given that EtOH, similar to pharmacologic mTOR inhibitors, inhibits mTOR signaling, we systematically explored the effect of EtOH and INK128 on mTOR signal transduction, components of the mTORC1/2 interaction and their downstream effectors in DLBCL malignancy. We found that EtOH partially inhibits mTOR signaling and protein translation, compared to INK128’s complete mTOR inhibition. Translatome analysis of mTOR downstream target genes established that differential inhibition of mTOR by EtOH and INK128 distinctly modulates translation of specific subsets of mRNAs involved in cell growth and survival, leading to differential cellular response and survival. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12964-015-0091-0) contains supplementary material, which is available to authorized users. BioMed Central 2015-03-01 /pmc/articles/PMC4350884/ /pubmed/25849580 http://dx.doi.org/10.1186/s12964-015-0091-0 Text en © Mazan-Mamczarz et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mazan-Mamczarz, Krystyna
Peroutka, Raymond J
Steinhardt, James J
Gidoni, Moriah
Zhang, Yongqing
Lehrmann, Elin
Landon, Ari L
Dai, Bojie
Houng, Simone
Muniandy, Parameswary A
Efroni, Sol
Becker, Kevin G
Gartenhaus, Ronald B
Distinct inhibitory effects on mTOR signaling by ethanol and INK128 in diffuse large B-cell lymphoma
title Distinct inhibitory effects on mTOR signaling by ethanol and INK128 in diffuse large B-cell lymphoma
title_full Distinct inhibitory effects on mTOR signaling by ethanol and INK128 in diffuse large B-cell lymphoma
title_fullStr Distinct inhibitory effects on mTOR signaling by ethanol and INK128 in diffuse large B-cell lymphoma
title_full_unstemmed Distinct inhibitory effects on mTOR signaling by ethanol and INK128 in diffuse large B-cell lymphoma
title_short Distinct inhibitory effects on mTOR signaling by ethanol and INK128 in diffuse large B-cell lymphoma
title_sort distinct inhibitory effects on mtor signaling by ethanol and ink128 in diffuse large b-cell lymphoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350884/
https://www.ncbi.nlm.nih.gov/pubmed/25849580
http://dx.doi.org/10.1186/s12964-015-0091-0
work_keys_str_mv AT mazanmamczarzkrystyna distinctinhibitoryeffectsonmtorsignalingbyethanolandink128indiffuselargebcelllymphoma
AT peroutkaraymondj distinctinhibitoryeffectsonmtorsignalingbyethanolandink128indiffuselargebcelllymphoma
AT steinhardtjamesj distinctinhibitoryeffectsonmtorsignalingbyethanolandink128indiffuselargebcelllymphoma
AT gidonimoriah distinctinhibitoryeffectsonmtorsignalingbyethanolandink128indiffuselargebcelllymphoma
AT zhangyongqing distinctinhibitoryeffectsonmtorsignalingbyethanolandink128indiffuselargebcelllymphoma
AT lehrmannelin distinctinhibitoryeffectsonmtorsignalingbyethanolandink128indiffuselargebcelllymphoma
AT landonaril distinctinhibitoryeffectsonmtorsignalingbyethanolandink128indiffuselargebcelllymphoma
AT daibojie distinctinhibitoryeffectsonmtorsignalingbyethanolandink128indiffuselargebcelllymphoma
AT houngsimone distinctinhibitoryeffectsonmtorsignalingbyethanolandink128indiffuselargebcelllymphoma
AT muniandyparameswarya distinctinhibitoryeffectsonmtorsignalingbyethanolandink128indiffuselargebcelllymphoma
AT efronisol distinctinhibitoryeffectsonmtorsignalingbyethanolandink128indiffuselargebcelllymphoma
AT beckerkeving distinctinhibitoryeffectsonmtorsignalingbyethanolandink128indiffuselargebcelllymphoma
AT gartenhausronaldb distinctinhibitoryeffectsonmtorsignalingbyethanolandink128indiffuselargebcelllymphoma